Mobile-health Network Solutions (MNDR) Stock Analysis
Verdict: AVOID
Severe cash burn with under 3 months of runway and a 36.4% revenue decline create extreme dilution and solvency risks.
Investment score: 9/100
Analysis as of
Is Mobile-health Network Solutions stock worth reviewing? AI model thesis
The AI model recommends AVOID for MNDR due to an imminent liquidity crisis (~2.9 months of cash runway), sharp revenue contraction (-36.44%), and severe ongoing technical breakdown (-40.78% single-day drop).
7-factor investment score
- Valuation: 5/100 (weight 20%)
- Financial Health: 5/100 (weight 15%)
- Technical Momentum: 5/100 (weight 15%)
- Earnings Quality: 10/100 (weight 15%)
- Insider Sentiment: 20/100 (weight 10%)
- Analyst Consensus: 25/100 (weight 10%)
- Risk-Adjusted Return: 5/100 (weight 15%)
Mobile-health Network Solutions opportunities and risks
What speaks for MNDR
- Expansion of MaNaCare Corporate Wellness Services
What speaks against MNDR
- Acute Solvency Crisis and Imminent Dilution Risk
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| MNDR | n/a | 0.0x | 1.4x | -1.5% | -35.1% | -15072.5% |
| BMGL | n/a | 0.5x | n/a | -2.4% | -67.7% | -35.7% |
| Peer median | n/a | 0.5x | n/a | -2.4% | -67.7% | -35.7% |
Frequently asked questions about Mobile-health Network Solutions (MNDR)
Is MNDR stock a good investment?
The cached TradeMates AI model rates Mobile-health Network Solutions as AVOID with an investment score of 9/100. The AI model recommends AVOID for MNDR due to an imminent liquidity crisis (~2.9 months of cash runway), sharp revenue contraction (-36.44%), and severe ongoing technical breakdown (-40.78% single-day drop). This is algorithmic model output, not personal investment advice.
Is MNDR stock a buy?
The TradeMates model verdict for MNDR is AVOID with an investment score of 9/100. Treat this as a model signal to review, not a personal buy recommendation.